Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division
May 06, 2024 06:00 ET
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterinary Health...
Brains Bioceutical Corp, the Global Leader in Natural Cannabinoid APIs, Introduces Revolutionary Solid THC, Ushering in a New Era of Clinical Research
March 05, 2024 01:00 ET
|
Brains Bioceutical Corp
Vancouver, Canada & London, United Kingdom, March 05, 2024 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains Bio” or the “Company”), Brains Bio, a pioneer in the cannabinoid-based...
Prati-Donaduzzi Secures the Largest Global Pharma Supply Agreement for Natural Cannabinoids with API Manufacturer Brains Bioceutical
April 04, 2023 01:00 ET
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, April 04, 2023 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains Bio” or the “Company”), the largest natural cannabinoid active pharmaceutical ingredient (“API”)...
Brains Bio Receives NSF’s First CBD Certification for EU GMP CBD API
November 22, 2022 06:00 ET
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp ("Brains Bio" or the "Company"), a global leader in EU GMP grade Cannabidiol (CBD) has received NSF GMP...
Brains Bioceutical Opens UK’s Largest EU GMP-Grade Licensed Cannabinoid Research and Commercial Production Facility
September 29, 2022 01:00 ET
|
Brains Bioceutical Corp
VANCOUVER, British Columbia and SANDWICH, United Kingdom, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains” or the “Company”), is pleased to announce the opening of its recently...
Brains Bioceutical Inaugura a Maior Instalação de Pesquisa e Produção Comercial de Canabinóides Licenciados de Grau BPF da UE no Reino Unido
September 29, 2022 01:00 ET
|
Brains Bioceutical Corp
VANCOUVER, British Columbia e SANDWICH, Reino Unido, Sept. 29, 2022 (GLOBE NEWSWIRE) -- A Brains Bioceutical Corp (“Brains” ou a “Empresa”) tem o prazer de anunciar a inauguração da sua instalação...
Brains Bioceutical inaugura la mayor instalación de investigación y producción comercial de cannabinoides con licencia de grado BPF de la UE en el Reino Unido
September 29, 2022 01:00 ET
|
Brains Bioceutical Corp
VANCOUVER, Columbia Británica y SANDWICH, Reino Unido, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains” o la “Empresa”), se complace en anunciar la inauguración de su...
Brains Bioceutical Corp. logra un aumento de capital de 31,9 millones de USD con el inversor principal DSM Venturing
June 17, 2021 16:51 ET
|
Brains Bioceutical Corp
VANCOUVER, Columbia Británica, June 17, 2021 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. (en adelante, «Brains» o la «Empresa») se complace en anunciar la consecución de un aumento de capital...
Brains Bioceutical Corp. завершило привлечение капитала на сумму 31,9 миллиона долларов США с ведущим инвестором DSM Venturing
June 17, 2021 16:51 ET
|
Brains Bioceutical Corp
ВАНКУВЕР, Британская Колумбия, June 17, 2021 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. («Brains” or the “Company») рада объявить о завершении привлечения капитала в размере 31,9 млн долларов США...
Brains Bioceutical Corp. completa un'operazione di aumento di capitale da 31,9 milioni di dollari con l'investitore principale, DSM Venturing
June 17, 2021 16:51 ET
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, June 17, 2021 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. (qui di seguito "Brains" o la "Società") è lieta di annunciare il completamento dell'operazione di aumento di...